We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$280M
AUM Growth
-$7.34M
Cap. Flow
-$22.2M
Cap. Flow %
-7.92%
Top 10 Hldgs %
45.64%
Holding
951
New
8
Increased
46
Reduced
212
Closed
452

Top Buys

Rank Stock Value
1
DELL icon
Dell
DELL
+$3.14M
2
CB icon
Chubb
CB
+$208K
3
PFFD icon
Global X US Preferred ETF
PFFD
+$151K
4
TEL icon
TE Connectivity
TEL
+$138K
5
ANET icon
Arista Networks
ANET
+$80.1K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.52M
2
XOM icon
ExxonMobil
XOM
+$1.48M
3
CVX icon
Chevron
CVX
+$1.23M
4
LLY icon
Eli Lilly
LLY
+$866K
5
JPM icon
JPMorgan Chase
JPM
+$783K

Sector Composition

Rank Sector Weight
1 Technology 48.17%
2 Healthcare 8.71%
3 Consumer Staples 8.37%
4 Industrials 6.34%
5 Financials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
401
D.R. Horton
DHI
$41B
$5.72K ﹤0.01%
30
-444
-94% -$78K
FXI icon
402
iShares China Large-Cap ETF
FXI
$4.31B
$5.72K ﹤0.01%
180
CRSP icon
403
CRISPR Therapeutics
CRSP
$4.58B
$5.45K ﹤0.01%
116
SGOV icon
404
iShares 0-3 Month Treasury Bond ETF
SGOV
$98.6B
$5.44K ﹤0.01%
54
CVS icon
405
CVS Health
CVS
$137B
$5.34K ﹤0.01%
85
-270
-76% -$15.8K
CAH icon
406
Cardinal Health
CAH
$53.4B
$5.03K ﹤0.01%
45
UNP icon
407
Union Pacific
UNP
$183B
$4.93K ﹤0.01%
20
LRCX icon
408
Lam Research
LRCX
$382B
$4.91K ﹤0.01%
60
-80
-57% -$6.96K
RWO icon
409
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
$4.9K ﹤0.01%
103
UTWO icon
410
US Treasury 2 Year Note ETF
UTWO
$482M
$4.88K ﹤0.01%
100
HYDB icon
411
iShares High Yield Systematic Bond ETF
HYDB
$1.62B
$4.81K ﹤0.01%
100
GE icon
412
GE Aerospace
GE
$367B
$4.78K ﹤0.01%
25
-2,552
-99% -$432K
RGEN icon
413
Repligen
RGEN
$7.44B
$4.46K ﹤0.01%
30
TNDM icon
414
Tandem Diabetes Care
TNDM
$1.17B
$4.24K ﹤0.01%
100
-188
-65% -$7.97K
REGN icon
415
Regeneron Pharmaceuticals
REGN
$68.8B
$4.21K ﹤0.01%
4
BA icon
416
Boeing
BA
$165B
$4.11K ﹤0.01%
27
-311
-92% -$53.3K
SJNK icon
417
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$3.86K ﹤0.01%
150
-938
-86% -$23.7K
ALNY icon
418
Alnylam Pharmaceuticals
ALNY
$36.3B
$3.85K ﹤0.01%
14
SLB icon
419
SLB Ltd
SLB
$77.8B
$3.8K ﹤0.01%
90
-3,268
-97% -$145K
EDIV icon
420
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$3.77K ﹤0.01%
100
-155
-61% -$5.59K
NMM icon
421
Navios Maritime Partners
NMM
$2.25B
$3.44K ﹤0.01%
55
LNTH icon
422
Lantheus
LNTH
$6.82B
$3.4K ﹤0.01%
31
BG icon
423
Bunge Global
BG
$23.6B
$3.29K ﹤0.01%
34
IVOO icon
424
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$3.18K ﹤0.01%
30
M icon
425
Macy's
M
$6.15B
$3.17K ﹤0.01%
200

Similar funds

Front Row Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Front Row Advisors held 951 positions worth $280M, down 2.6% from $288M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Front Row Advisors withdrew a net $22.2M in Q3 2024, closing 452 positions and reducing 212 holdings. Its most notable exit was Vanguard Information Technology ETF, an estimated $578K position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Front Row Advisors opened a new position in Global X US Preferred ETF worth $156K.

  • Front Row Advisors's largest Q3 2024 buy was Global X US Preferred ETF: 7,500 shares worth $156K.
  • Front Row Advisors added most to Dell in Q3 2024, an estimated $3.14M increase.
  • Front Row Advisors's biggest Q3 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $1.52M.
  • Front Row Advisors fully exited Vanguard Information Technology ETF in Q3 2024, selling an estimated $578K.
  • Front Row Advisors's ten largest holdings make up 46% of its $280M portfolio in Q3 2024.
  • Front Row Advisors opened 8 new positions and closed 452 in Q3 2024.
  • Front Row Advisors's portfolio value fell 2.6% quarter-over-quarter to $280M.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.